Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Trivsel og healing ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.1% 12.2% 16.1% 19.4% 16.5% 15.4% 21.2% 21.2%   Credit score (0-100)   21 21 11 6 10 12 5 5   Credit rating   BB BB BB B BB BB B B   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 -0.0 -0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 367 274 0 0 0 0 0   Gross profit   217 147 151 -4.1 0.0 0.9 0.0 0.0   EBITDA   217 -155 -45.3 -4.1 0.0 0.9 0.0 0.0   EBIT   217 -155 -45.3 -4.1 0.0 0.9 0.0 0.0   Pre-tax profit (PTP)   214.9 -157.9 -49.6 -6.1 0.0 -2.1 0.0 0.0   Net earnings   166.0 -125.4 -40.6 -4.7 0.0 -2.1 0.0 0.0   Pre-tax profit without non-rec. items   215 -158 -49.6 -6.1 0.0 -2.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   234 108 -37.9 -42.6 -42.6 -41.7 13.8 13.8   Interest-bearing liabilities   0.0 0.0 0.0 65.1 65.1 75.1 0.0 0.0   Balance sheet total (assets)   328 264 43.0 58.3 58.3 59.9 13.8 13.8   Net Debt   -145 -76.2 -1.5 64.6 64.6 73.1 -13.8 -13.8     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 367 274 0 0 0 0 0   Net sales growth   0.0% 0.0% -25.3% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   217 147 151 -4.1 0.0 0.9 0.0 0.0   Gross profit growth   -41.3% -32.2% 2.8% 0.0% 0.0% 0.0% -100.0% 0.0%   Employees   1 1 1 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   328 264 43 58 58 60 14 14   Balance sheet change%   163.9% -19.4% -83.7% 35.5% 0.0% 2.7% -76.9% 0.0%   Added value   216.8 -154.7 -45.3 -4.1 0.0 0.9 0.0 0.0   Added value %   0.0% -42.2% -16.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 -1.0 -2.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 -3.0 0.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% -42.2% -16.5% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% -42.2% -16.5% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% -105.3% -29.9% 100.0% 0.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% -34.2% -14.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% -34.2% -14.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% -43.1% -18.1% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   95.8% -52.2% -26.2% -4.5% 0.0% 0.9% 0.0% 0.0%   ROI %   144.0% -90.5% -83.6% -12.6% 0.0% 1.3% 0.0% 0.0%   ROE %   110.3% -73.4% -53.7% -9.3% 0.0% -3.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   71.2% 40.9% -46.8% -42.2% -42.2% -41.1% 100.0% 100.0%   Relative indebtedness %   0.0% 42.6% 29.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 21.8% 29.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -67.0% 49.2% 3.4% -1,581.6% 0.0% 8,226.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% -152.7% -152.7% -180.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 6.1% 0.0% 4.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.5 1.7 0.5 0.6 0.6 0.6 0.0 0.0   Current Ratio   3.5 1.7 0.5 0.6 0.6 0.6 0.0 0.0   Cash and cash equivalent   145.2 76.2 1.5 0.5 0.5 2.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 155.1 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 159.2 44.9 567.3 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 72.1% 15.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   233.6 108.2 -37.9 -42.6 -42.6 -41.7 0.0 0.0   Net working capital %   0.0% 29.5% -13.8% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 367 274 0 0 0 0 0   Added value / employee   217 -155 -45 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   217 -155 -45 0 0 0 0 0   EBIT / employee   217 -155 -45 0 0 0 0 0   Net earnings / employee   166 -125 -41 0 0 0 0 0